跳至主要内容
临床试验/KCT0001625
KCT0001625已完成未知

A comparative study of 24-hour and 6-hour Infusion of Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis: a Prospective Randomized Comparison Trial

Pusan National University Yangsan Hospital0 个研究点目标入组 256 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
256

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • All patients with an intact papilla and known or suspected pancreatobiliary disease, who are candidates for therapeutic or diagnostic biliary ERCP at a single tertiary referral center (Pusan National University Yangsan Hospital), were scheduled to participate in the study.

排除标准

  • Patients were excluded for any of the following reasons: age younger than 18 years, previous history of precut or biliary sphicterotomy, previous history of biliary or pancreatic stenting, repeated ERCP, clinical evidence of acute pancreatitis at the time of procedure, treatment with nafamostat mesilate or other protease inhibitors in the last 7 days, pregnancy and refusal to participate.

研究者

相似试验

A comparative study of 24-hour and 6-hour Infusion... | 临床试验